Inventor
Stephen G. Will
Inventor
Oakland, CA, US
Overview
Patents· 49 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms51%
C07HSugars13%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests13%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations3%
C12NMicroorganisms or enzymes3%
A41DOuterwear2%
D06FLaundering, drying, ironing, pressing or folding textile articles2%
A61BDiagnosis1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
11,078,534Photocleavable nucleotide reagents with high stability202110,752,891Protein-based sample collection matrices and devices202010,663,379Plasma separation card202010,119,161Methods and kits for joining fragmented nucleic acids together20189,909,169'Allele-specific amplification of nucleic acids using blocking oligonucleotides for wild type suppression'20189,745,618'Photoblocked probes and methods for sequential detection of nucleic acids'20179,506,111'Allele-specific amplification'20169,410,195'Methods and reagents for reducing non-specific amplification'20169,400,235'Alkyl amines improve detection of components of formaldehyde-fixed biological samples'20169,371,524'Amine compounds for the selective preparation of biological samples'20169,238,832'Allele-specific amplification of nucleic acids'20169,234,250'Control nucleic acids for multiple parameters'20169,175,332'Generic PCR'20159,115,394'Methods and reagents for reducing non-specific amplification'20159,068,225'Format of probes to detect nucleic acid differences'20158,669,061'Method for the prevention of carryover contamination in nucleic acid amplification technologies'20148,658,366'Detection of target variants using a fluorescent label and a soluble quencher'20148,652,775'Alkyl amines improve detection of components of formaldehyde-fixed biological samples'20148,614,071'Preferential amplification of mRNA over DNA using chemically modified primers'20138,609,340'Control nucleic acids for multiple parameters'20138,586,299'Allele-specific amplification'20138,409,802'Format of probes to detect nucleic acid differences'20138,222,003'Probes and methods for hepatitis C virus typing using single probe analysis'20128,202,975'High-risk human papillomavirus detection'20128,198,422'High-risk human papillomavirus detection'20128,198,423'High-risk human papillomavirus detection'20128,163,484'Light emission modifiers and their uses in nucleic acid detection, amplification and analysis'20128,163,487'2′-terminator nucleotide-related methods and systems'20128,119,346'Light emission modifiers and their uses in nucleic acid detection, amplification and analysis'20128,114,595'Light emission modifiers and their uses in nucleic acid detection, amplification and analysis'20128,067,208'Probes and methods for hepatitis C virus typing using multidimensional probe analysis'20118,058,423'High-risk human papillomavirus detection'20117,977,108'Method for detecting a mutation in a repetitive nucleic acid sequence'20117,947,817'Synthesis and compositions of 2\'-terminator nucleotides'20117,928,207'Synthesis and compositions of nucleic acids comprising 2′-terminator nucleotides'20117,919,249'2′-Terminator nucleotide-related methods and systems'20117,919,242'Light emission modifiers and their uses in nucleic acid detection, amplification and analysis'20117,858,772'Compounds and methods for synthesis and purification of oligonucleotides'20107,741,467'Non-fluorescent energy transfer'20107,572,581'2′-terminator nucleotide-related methods and systems'20097,501,504'Detectable labeled nucleoside analogs and methods of use thereof'20097,482,142'High-risk human papillomavirus detection'20097,465,561'Probes and methods for hepatitis C virus typing using single probe analysis'20087,456,266'Detectable labeled nucleoside analogs and methods of use thereof'20087,452,674'Detectable labeled nucleoside analogs and methods of use thereof'20087,220,847'Detectable labeled nucleoside analogs and methods of use thereof'20076,062,444'Folded surgical gown for aseptic donning apparatus and method for producing same'20006,001,611'Modified nucleic acid amplification primers'19995,862,525'Folded surgical gown for aseptic donning, apparatus and method for producing same'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2021Patents assigned to ROCHE MOLECULAR SYSTEMS INC (47)· patent assignee history
1999–2000Based in Marietta, GA, US· patent location history
1999Based in Walnut Creek, CA, US· patent location history
2007–2021Based in Oakland, CA, US· patent location history
2011–2014Patents assigned to GUPTA AMAR P (6)· patent assignee history
2011–2014Patents assigned to WILL STEPHEN GORDON (6)· patent assignee history
2011–2012Patents assigned to ALDRICH CARRIE L (4)· patent assignee history
2012–2015Patents assigned to WILL STEPHEN G (10)· patent assignee history
2012–2016Based in Cham, CH· patent location history
2012–2013Based in Rotkreuz, CH· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ROCHE MOLECULAR SYSTEMS INC | 47 | 1999–2021 |
| WILL STEPHEN Gself | 10 | 2012–2015 |
| GUPTA AMAR P | 6 | 2011–2014 |
| WILL STEPHEN GORDONself | 6 | 2011–2014 |
| ALDRICH CARRIE L | 4 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Oakland, California, US | 29 | 2007–2021 |
| Cham, CH | 13 | 2012–2016 |
| Rotkreuz, CH | 4 | 2012–2013 |
| Marietta, Georgia, US | 2 | 1999–2000 |
| Walnut Creek, California, US | 1 | 1999 |